David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
Among the biggest losers in Monday’s early trading are Titan Machinery (Nasdaq: TITN) and Geron (nasdaq: GERN). The drought of 2012 is just starting to show up in quarterly reports, and investors are in no mood to take the long view: Drought-related profit… Read More
If you’re like me, then you’ve grown dependent on a digital video recorder (DVR) for your evening’s entertainment. The ability to store hours of my favorite shows — and access them instantly — was only hinted at when video-tape recorders (VCRs) were first introduced in the 1980s. But as it… Read More
If you keep a close eye on the stock market and the economy, then it’s crucial that you tune out the daily noise. There are so many data points we process that… Read More
Among the biggest winners in Friday’s early trading are Smith & Wesson (Nasdaq: SWHC) and Cooper Cos. (NYSE: COO). Soon after President Obama took office, gun sellers did a brisk amount of business on fears that firearms laws would soon become more restrictive. This chart of… Read More
Among the biggest losers in Friday’s early trading are InfoBlox (Nasdaq: BLOX), Pandora (NYSE: P) and Mattress Firm Holdings (Nasdaq: MFRM). Whenever a company says its plans to ramp up internal spending to meet future growth plans, it can mean… Read More
When it comes to investing biotech stocks, it’s wise to focus on companies that have completed much of their drug development work. The closer a company gets to the finish line in the clinical-testing process, the less chance that a drug will fail — taking the company’s stock down sharply.#-ad_banner-#… Read More
Among the biggest losers in Friday’s early trading are VeriFone Systems (NYSE: PAY) and OCZ Technologies (NYSE: OCZ). “Please swipe here” is a phrase you’ve heard at countless checkout counters, and when you look down, you’ve often seen the name VeriFone. The company’s card-swiping machines are so ubiquitous in… Read More
Among the biggest winners in Thursday’s early trading are The Men’s Wearhouse (NYSE: MW) and Merge Healthcare (Nasdaq: MRGE). Suiting up Fast on the heels of a solid quarterly report last week from men’s clothier Jos. A Bank (NYSE: JOSB) rival, The… Read More
After surging from less than $100 in early 2009 to a recent $670, Apple (Nasdaq: AAPL) has now an equal number of supporters and detractors. Analysts who follow Apple know that it continues to churn out segment-busting products, and they note… Read More
Among the biggest losers in Tuesday’s early trading are AuRico Gold (NYSE: AUQ) and Francesca’s Holdings (Nasdaq: FRAN). When companies have to deliver bad news, they sometimes turn to a professional group of publicists that work in investor relations (… Read More
